Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 21/4/2017
SIETES contiene 91761 citas

 
 
 1 a 20 de 278 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Trifirò G, de Ridder M, Sultana J, Oteri A, Rijnbeek P, Pecchioli S, Mazzaglia G, Bezemer I, Garbe E, Schink T, Poluzzi E, Froslev T, Molokhia M, Diemberger I, Sturkenboom M. Use of azithromycin and risk of ventricular arrhytmia. CMAJ 2017;189:E560-8. [Ref.ID 101536]
2. Cita con resumen
Johnston SL, Szigeti M, Cross M, Brightling C, Chaudhuri R, Harrison T, Mansur A, Robison L, Sattar Z, Jackson D, Mallia P, Wong E, Corrigan C, Higgins B, Ind P, Singh D, Thomson NC, Ashby D, Chauhan A, AZALEA Trial Team. Azithromycin for acute exacerbations of asthma: the AZALEA randomized clinical trial. JAMA 2016;176:1630-7. [Ref.ID 100957]
3.Tiene citas relacionadas
Weinstein RA, Boyer KM. Antibiotic prophylaxis for cesarean delivery - When broader is better. N Engl J Med 2016;375:1284-6. [Ref.ID 100771]
4.Tiene citas relacionadas Cita con resumen
Tita ATN, Szychowski JM, Boggess K, Saade G, Longo S, Esplin S, Cleary K, Wapner R, Letson K, Owens M, Abramovici A, Ambalavanan N, Cutter G, Andrews W, for the C/SOAP Trial Consortium. Adjunctive azithromycin prophylaxis for cesarean delivery. N Engl J Med 2016;375:1231-41. [Ref.ID 100770]
6. Cita con resumen
Schachter J. Azithromycin versus doxycycline for Chlamydia. N Engl J Med 2016;374:1786-7. [Ref.ID 100225]
7. Cita con resumen
Anónimo. QT interval and drug therapy. Drug Ther Bull 2016;54:33-6. [Ref.ID 100134]
8.Tiene citas relacionadas Cita con resumen
Wong AYS, Root A, Dogulas IJ, Chui CSL, Chan EW, Ghebremichael-Weldeselassie Y, Siu CW, Smeeth L, Wong ICK. Cardiovascular outcomes associated with use of clarithromycin: population based study. BMJ 2016;352:h6926. [Ref.ID 99982]
9.Tiene citas relacionadas Cita con resumen
Iyer G, Alexander GC. Cardiovascular risks associated with clarithromycin. BMJ 2016;352:i23. [Ref.ID 99980]
10.Enlace a cita original
Mehta S, Pulungan Z, JOnes BT, Teigland C. Comparative safety of atypical antipsychotics and the risk of pneumonia in the elderly. Pharmacoepidemiol Drug Saf 2015;24:1271-80. [Ref.ID 99788]
11. Cita con resumen
Bacharier LB, Guilbert TW, Mauger DT, Boehmer S, Beigelman A, Fitzpatrick AM, Jackson DJ, Baxi SN, Benson M, Burnham C-AD, Cabana M, Castro M, Chmiel JF, Covar R, Daines M, Gaffin JM, Gentile DA, Holguin F, Israel E, Kelly HW, Lazarus SC, Lemanske Jr RF, Meade K, Morgan W, Moy J, Olin T, Peters SP, Phipatanakul W, Pongracic JA, Raissy HH, Ross K, Sheehan WJ, Sorkness C, Szefler SJ, Teague WG, Thyne S, Martinez FD, for the National Heart Lung and Blood Institute's AsthmaNet. Early administration of azithromycin and prevention of severe lower respiratory tract illnesses in preschool children with a history of such illnesses: a randomized clinical trial. JAMA 2015;314:2034-44. [Ref.ID 99768]
12. Cita con resumen
Geisler WM, Uniyal A, Lee JY, Lensing SY, Johnson S, Perry RCW, Kadrnka CM, Kerndt PR. Azithromycin versus doxycycline for urogenital Chlamydia trachomatis infection. N Engl J Med 2015;373:2512-21. [Ref.ID 99766]
13. Cita con resumen
Bérard A, Sheehy O, Zhao J-P, Nordeng H. Use of macrolides during pregnancy and the risk of birth defects: a population-based study. Pharmacoepidemiol Drug Saf 2015;24:1241-8. [Ref.ID 99577]
14. Cita con resumen
Mitjà O, Houinei W, Moses P, Kapa A, Paru R, Hays R, Lukehart S, Godornes C, Bieb SV, Grice T, Siba P, Mabey D, Sanz S, Alonso PL, Asiedu K, Bassat Q. Mass treatment with single-dose azithromycin for yaws. N Engl J Med 2015;372:703-10. [Ref.ID 98808]
15. Cita con resumen
Li DQ, Kim R, McArthur E, Fleet JL, Bailey DG, Juurlink D, Shariff SZ, Gomes T, Mamdani M, Gandhi S, Dixon S, Garg AX. Risk of adverse events among older adults following co-prescription of clarithromycin and statins not metabolized by cytochrome P450 3A4. Can Med Assoc J 2015;187:174-80. [Ref.ID 98758]
16. Cita con resumen
Mortensen EM, Halm EA, Pugh MJ, Copeland LA, Metersky M, Fine MJ, Johnson CS, Alvarez CA, Frel CR, Good C, Restrepo MI, Downs JR, Anzueto A. Association of azithromycin with mortality and cardiovascular events among older patients hospitalized with pneumonia. JAMA 2014;311:2199-208. [Ref.ID 97670]
18. Cita con resumen
Rao GA, Mann JR, Shoaibi A, Lee Bennett C, Nahhas G, Sutton SS, Jacob S, Strayer SM. Azithromycin and levofloxacin use and increased risk of cardiac arrhythmia and death. Ann Fam Med 2014;12:121-7. [Ref.ID 97224]
19. Cita con resumen
Gandhi S, Fleet JL, Bailey DG, McArthur E, Wald R, Rehman F, Garg AX. Calcium-channel blocker-clarithromycin drug interactions and acute kidney injury. JAMA 2013;310:2544-53. [Ref.ID 96675]
20.Tiene citas relacionadas Cita con resumen
McMurray JJV, Jhund PS. Cardiovascular risks with azithromycin. N Engl J Med 2013;369:579. [Ref.ID 95973]
Seleccionar todas
 
 1 a 20 de 278 siguiente >>